[ET Net News Agency, 5 January 2026] HANSOH PHARMA (03692) rose 3.3% to HK$37.66.
It hits an intra-day high of HK$37.66, breaking above the 100-D SMA of HK$37.378, and an
intra-day low of HK$35.7. The total shares traded was 3 million, with a value of
HK$109.78m. The active buy/sell ratio is 62:38, with net buying turnover of HK$24.74m.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive buying turnover of HK$1.12m,
with volume weighted average price of HK$36.687. HSBC SEC BRO (ASIA) accounts for greatest
net responsive selling turnover of HK$7.27m, with volume weighted average price of
HK$36.549. The stock has risen a combined 4.4% over the past 2 consecutive trading days.
The Hang Seng Index now rose 78 points, or 0.3% to 26,416.

Basic Information
=================

----------------------------------
Nominal 37.660 % Chg +3.35%
High 37.660 Low 35.700
Shares Tr 3m Turnover 109.78m
10-D SMA 37.462 %H.V 34.645
20-D SMA 39.388 VWAP 36.570
50-D SMA 38.371 RSI14 44.114
----------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 62:38, with net buying
turnover of HK$24.74m, rising a combined 4.4% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 37.66 +3.35
GRAND PHARMA (00512) 7.89 +1.15
CSPC PHARMA (01093) 8.79 +3.66
SINO BIOPHARM (01177) 6.45 +1.42
HENGRUI PHARMA (01276) 76.15 +2.77
INNOVENT BIO (01801) 83.10 +5.46
WUXI BIO (02269) 33.24 +2.15
WUXI APPTEC (02359) 104.80 +3.76
BEONE MEDICINES (06160) 195.50 +5.96
AKESO (09926) 117.50 +3.71
-----------------------------------------------
(ed)